Login
SDU
中文
Home
Scientific Research
Working-Papers
Paper Publications
Patents
Published Books
Research Projects
Research Team
Teaching Research
Teaching Resources
Teaching Experience
Teaching Achievement
Awards and Honours
Enrollment Information
Student Information
My Album
Blog
Current position:
Home
>>
Scientific Research
>>
Paper Publications
刘新泳
Personal Information
Professor
Paper Publications
[391] liuxinyong and guoxiuli. DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF.... J Pharmacy Pharmacology, 66, 398, 2014.
[392] liuxinyong and 展鹏. Design, synthesis and acetylcholinesterase (AChE) inhibition assay of novel 9-(1-(substituted-be.... E-JOURNAL OF CHEMISTRY, 2013.
[393] liuxinyong and 展鹏. The HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors (Part V): Capravirine and Its Analogues. Curr Med Chem. 2012;19(36):6138-49., 2012.
[394] liuxinyong and 展鹏. Discovery of novel pyridazinylthioacetamides as potent HIV-1 NNRTIs using a structure-based biois.... Med. Chem. Commun., 2013,4, 810-816., 2013.
[395] liuxinyong and 展鹏. Multivalent agents: a novel concept and preliminary practice in anti-HIV drug discovery. Curr Med Chem. 2013 Feb 1;20(6):815-32., 2013.
[396] liuxinyong and 展鹏. Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Relat.... Curr Pharm Des. 2013;19(8):1528-48., 2013.
[397] liuxinyong and 展鹏. Arylazolyl(azinyl)thioacetanilides. Part 10: Design, synthesis and biological evaluation of novel.... 《Bioorg Med Chem.》, 20, 5527, 2012.
[398] liuxinyong and 李潇. Arylazolyl(azinyl) thioacetanilides. Part 10: Design, synthesis and biological evaluation of nove.... Bioorg. Med. Chem., 20, 5527, 2012.
[399] liuxinyong and guoxiuli. 内质网应激介导的细胞凋亡途径及新靶点药物. 《中国药学杂志》, 43, 1361, 2008.
[400] liuxinyong , chengyanna and guoxiuli. Reversal effect of ligustrazine derivate on multi-drug resistance in adriamycin-resistant cell li.... Toxicology in vitro 2011,25(4):937-943, 25, 937, 2011.
total562 40/57
first
previous
next
last
Page